Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Country, Real-World Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients Diagnosed With Myelofibrosis Through Chart Review

NCT05444972 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05444972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05444972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Country, Real-World Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients Diagnosed With Myelofibrosis Through Chart Review
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
August 23, 2022
Completion date
November 14, 2023
Enrollment
998 (actual)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

myelofibrosis